卡维地洛

被引:7
作者
关战军
机构
[1] 第二军医大学!上海,
关键词
卡维地洛; 氧自由基; 血管平滑肌细胞;
D O I
10.13220/j.cnki.jipr.1995.03.004
中图分类号
R972 [心血管系统药物];
学科分类号
1007 ;
摘要
卡维地洛是一种新型的扩血管药,它可非选择性地阻断β-受体,选择性地阻断α1-受体,大剂量时有阻断钙通道的作用。最近发现,该药还具有抗氧化和清除自由基的作用,并能抑制离体和在体血管平滑肌细胞的增殖,说明该药是一有临床应用前景的新药。
引用
收藏
页码:141 / 143
页数:3
相关论文
共 8 条
[1]  
Carvedilolinhibits vascular smooth muscle cell prolifera-tion. Sung C-P,Arleth AJ,Ohlstein EH. Journal of Cardiovascular Pharmacology . 1993
[2]  
Atherosclerosis[P]. DONG CHUNMING;GOLDSCHMIDT PASCAL J.中国专利:US2008095751A1,2008-04-24
[3]  
Pharmacology[C]. 2002年中日毒理学和药理学联合研讨会,2002
[4]  
Carvedilol, a cardiovascular drug, prevents vas-cular smooth muscle cell proliferation, migra-tion, and neointimal formation following vascu-lar injury. Ohlstein EH,Douglas SA,Sung CP,et al. Proceedings of the National Academy of Sciences of the United States of America . 1993
[5]  
Carve-dilol, a new vasodilator and beta adrenoceptor an-tagonist, is an antioxidant and free radical scav-enger. Yue T-L,Cheng H-Y,Lysko PG,et al. Journal of Pharmacology and Experimental Therapeutics . 1992
[6]  
Cardiopro-tective effects of carvedilol in the models of my-ocardial infarction. Smith EF,Davis PA,DiMartino MJ. The FASEB Journal . 1991
[7]  
Cardio-protective effects of carvedilol, a novel β-adreno-ceptor antagonist with vasodilating properties, inanesthetized minipigs: comparison with propra-nolol. Bril A,Slivjak M,DiMartino MJ,et al. Cardiovascular Research . 1992
[8]  
Carvedilol (Kredex): a novel multip1e actioncardiovascular agent. Ruffolo HR,Jr Boyle P,Venuit RP,et al. Drugs of Today . 1991